Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

Edwards Lifesciences beat Q4 estimates with $1.39B in sales, driven by growth in TMTT, TAVR, and Surgical. The company ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, offers products and technologies for structural ...

Bleakley Financial Group LLC lowered its stake in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 5.3% during the 4th ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

A brand-new addition this year is the Pittcon Pups – meet adorable local dogs of all ages looking for their fur-ever home. Whether you’re just there for some puppy snuggles or hoping to meet your new ...

STORA ENSO OYJ FINANCIAL STATEMENT RELEASE 11 February 2025 at 8:30 EET HELSINKI, Feb. 11, 2025 /PRNewswire/ -- Q4/2024 (year-on-year) Sales increased by 7% to EUR 2,322 (2,174) ...

Cantor Fitzgerald lowered their FY2025 earnings per share (EPS) estimates for CVRx in a research report issued on Wednesday, ...

The market has misjudged the potential impact of DeepSeek's AI progress, interpreting it as a headwind for tech companies.

In addition to revenue growth, AstraZeneca's core earnings per share climbed 44% to $2.09. Research and development spending ...